CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Option exercise EVP, Chief Development Officer acquired 11,694 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 11,694 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 34,789 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Option exercise EVP, Chief Development Officer acquired 3,875 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 3,875 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 13,796 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 62,500 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 4/A Grant or award Director acquired 17,950 shares (grant or award)
- 4/A Grant or award Director acquired 17,950 shares (grant or award)
- 4/A Grant or award Director acquired 17,950 shares (grant or award)
- 4/A Grant or award Director acquired 17,950 shares (grant or award)
Page 7 of 77 · 1,527 filings